These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24632719)

  • 61. Treatment of cardiogenic shock. I.
    Cohen LS
    S D J Med; 1972 Oct; 25(10):13-5. PubMed ID: 4510160
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment of cardiogenic shock. I.
    Cohen LS
    J Maine Med Assoc; 1972 Sep; 63(9):212-3. PubMed ID: 5068938
    [No Abstract]   [Full Text] [Related]  

  • 63. Vasopressor and inotrope use in Canadian emergency departments: evidence based consensus guidelines.
    Djogovic D; MacDonald S; Wensel A; Green R; Loubani O; Archambault P; Bordeleau S; Messenger D; Szulewski A; Davidow J; Kircher J; Gray S; Smith K; Lee J; Benoit JM; Howes D
    CJEM; 2015 Jan; 17(1):1-2. PubMed ID: 25961083
    [No Abstract]   [Full Text] [Related]  

  • 64. Vasopressor and Inotrope Use in Canadian Emergency Departments: Evidence Based Consensus Guidelines.
    Djogovic D; MacDonald S; Wensel A; Green R; Loubani O; Archambault P; Bordeleau S; Messenger D; Szulewski A; Davidow J; Kircher J; Gray S; Smith K; Lee J; Marc Benoit J; Howes D
    CJEM; 2015 Feb; 17 Suppl 1():1-16. PubMed ID: 26067924
    [No Abstract]   [Full Text] [Related]  

  • 65. The evaluation and treatment of cardiogenic shock.
    Mueller HS; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
    Med Times; 1970 Jul; 98(7):137-52. PubMed ID: 5427663
    [No Abstract]   [Full Text] [Related]  

  • 66. Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.
    Ndrepepa G; Schömig A; Kastrati A
    JAMA; 2007 Apr; 297(15):1711-3. PubMed ID: 17440148
    [No Abstract]   [Full Text] [Related]  

  • 67. BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction.
    Emerg Med J; 2013 Dec; 30(12):1060-2. PubMed ID: 24232006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.
    Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiogenic shock in acute myocardial infarction.
    Dennison AD
    J Indiana State Med Assoc; 1968 Nov; 61(11):1537-9. PubMed ID: 5704471
    [No Abstract]   [Full Text] [Related]  

  • 71. [Vasopressor drugs in shock due to myocardial infarction].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Oct; 22(45):1744-7. PubMed ID: 4294154
    [No Abstract]   [Full Text] [Related]  

  • 72. [Catecholamines in internal medicine emergencies].
    Brandt D; Pristautz H; Klein W
    Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of cardiogenic shock. I.
    Cohen LS
    Conn Med; 1973 Aug; 37(8):397-9. PubMed ID: 4146942
    [No Abstract]   [Full Text] [Related]  

  • 74. [Drug therapy of cardiogenic shock. Improvement in hemodynamics is essential].
    Stiefelhagen P
    Med Monatsschr Pharm; 2010 Aug; 33(8):303-5. PubMed ID: 21189650
    [No Abstract]   [Full Text] [Related]  

  • 75. [Problems in the treatment of cardiogenic shock in myocardial infarct].
    Mihail A; Popescu P
    Med Interna (Bucur); 1969 Nov; 21(11):1301-10. PubMed ID: 5379697
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparison of dopamine and norepinephrine in shock.
    Tomoda H
    N Engl J Med; 2010 Jun; 362(24):2329-30; author reply 2330-1. PubMed ID: 20560181
    [No Abstract]   [Full Text] [Related]  

  • 77. Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.
    O'Brien ET; Howarth E; Singh SP
    J Ir Med Assoc; 1973 Aug; 66(15):415-7. PubMed ID: 4727938
    [No Abstract]   [Full Text] [Related]  

  • 78. [Digitalis and myocardial infarct].
    Heikkilä J
    Duodecim; 1974; 90(7):388-401. PubMed ID: 4603477
    [No Abstract]   [Full Text] [Related]  

  • 79. What is the role of positive inotropic agents in the treatment of acute myocardial infarction?
    Mason DT; Amsterdam EA; Miller RR; Williams DO
    Cardiovasc Clin; 1977; 8(1):113-22. PubMed ID: 849585
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of cardiogenic shock.
    Cohen LS
    Med Ann Dist Columbia; 1973 Mar; 42(3):133-5. PubMed ID: 4511901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.